Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
Condition: Bladder Cancer Intervention: Drug: Durvalumab Sponsors: Canadian Cancer Trials Group; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials